February 7-8, 2022
Philadelphia, PA
2nd Next-Gen MSL ExcellenceSummit
Encouraging Field Medical Professionals to Nurture Leadership Skills, Prioritize Work-Life Balance and Demonstrate Value to Stakeholders
MSLs already had uniquely demanding responsibilities for communicating and gathering key information – and that was before lockdowns and hybrid meetings. Throughout the pandemic, MSLs and field medical teams have been challenged to maintain their relationships with KOLs while prioritizing a work-life balance and advancing their careers.

DGE’s 2nd Next-Gen MSL Excellence Summit returns to provide MSLs and field medical professionals with must-have leadership, team-building and communication tools. Join us February 7-8 in Philadelphia for unequaled learning and networking about how to leverage new technologies, discern meaningful insights, improve stakeholder engagement, and prove value to the organization.

As DGE welcomes you back to in-person conferences, we assure you that every precaution will be taken to keep you safe and healthy at our events. We have set new protocols for social distancing, onsite cleansing, and vaccination guarantees, all to make sure you have the best possible experience for learning and networking with a community of your peers.

  • VACCINATION IS MANDATORY to participate in a DGE in-person event. All event staff, speakers, attendees, sponsors, and exhibitors must submit proof of vaccinated status upon first entry to the event space
  • All event staff, speakers, attendees, sponsors, and exhibitors must wear masks in all event spaces, except when speaking on stage or eating in designated socially-distanced locations
  • All participants must affirm that they are not experiencing symptoms, have not been to an area with a travel health advisory, and have not been closely exposed to anyone who was
  • All events will follow federal and local safety guidances, as well as additional regulations that may be in place for each venue
  • All seating and exhibition areas will allow for 3 feet of space between participants
  • Event staff will be constantly monitoring room capacity and density
  • New directional and distancing signage will help remind participants about social distancing while keeping foot traffic flowing smoothly
  • All event spaces will have enhanced cleaning protocols throughout your stay
  • DGE and hotel staff have been trained on rapid response if event participants begin to show symptoms of illness

We appreciate your trust and your willingness to resume in-person learning. We pledge to put your health and safety first while holding our educational conferences, and to continue to refine and improve those standards based on developing guidelines from governments and venues.

Top Reasons to Attend
  • Outline your professional objectives and develop a roadmap to achieve your career goals
  • Nurture leadership skills to advance in your medical affairs career
  • Sharpen communication and soft skills to enhance KOL engagements
  • Techniques to effectively collaborate with cross-functional teams and engaging in strategic planning
  • Innovative methods to leverage AI and social media to gather insights and influence medical strategies
  • Ample networking opportunities with field medical professionals and industry leaders in a live conference setting
Who Should Attend

This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:

  • Medical Science Liaison (MSL)
  • MSL Manager
  • Field Medical Director
  • Managed Care Liaison
  • Medical Value Liaison
  • Medical Outcomes Science Liaison
  • Health Outcomes Liaison
  • Managed Outcomes Liaison
  • Clinical Trial Liaison (CTL)
  • Clinical Science Liaison
  • Community Medical Liaison
  • Public Health Liaison
  • MSL Excellence
  • Field Medical Excellence
  • Field Medical Capabilities
  • Medical Affairs
  • Medical Director/Advisor
  • Medical Scientific Manager
  • Scientific Medical Affairs
  • Scientific Communications
  • Medical Launch Excellence
  • KOL/Thought Leader Engagement
  • Medical Communication/Information
  • Product Lifecycle Management
  • Clinical Development/Scientific Affairs
  • Compliance
This event will also be of interest to:
  • Contract Research Organizations (CROs)
  • KOL Monitoring & Engagement Service Providers
  • Medical Affairs Staffing & Recruiting Firms
  • Insight Management Providers
Event Sponsors
New Topics
Featured Speakers
Abisoye Adenola
Senior Medical Science Liaison
LEO Pharma
Alex Bitting
Director, Medical Outcomes Science Liaison – Central US
Bobby Faison
National Liaison Lead
Brian Carroll
Medical Science Liaison
Spectrum Pharmaceuticals
Bryan N. Bischel, PhD
Medical Director, Hepatology
Carolina Lowe
Director, Field Medical Affairs
United Therapeutics
Christina Wright
MSL Lead, Immunology
TG Therapeutics
Christy Smith
Associate Director, US Oncology MSL Team
Kyowa Kirin
Ed Paiewonsky
Senior Managed Care Liaison
Neurocrine Biosciences
Edward Power
Vice President, North America Medical Affairs, Hospital Business
Harmony Garges
Senior Vice President, Chief Medical Officer and Head of Global Medical
ViiV Healthcare
James Siano
US Regional Director, Medical Affairs – Biosimilars
Javier Sanchez-Padilla
Senior Medical Science Liaison
Jazz Pharmaceuticals
Kartik Aysola
Director, Medical Affairs
Orbus Therapeutics
Kunal Ramani
Regional Medical Affairs Director
Laura Guido
Medical Director
Leann Pezdirtz
Head, Field Based Medicine
Leona Blustein
Senior Director, Head of US Medical Affairs Operations
Idorsia Pharmaceuticals
Lisa Berge
Senior Director, Medical Affairs
Aveo Pharmaceuticals
Melissa Downey
MSL Field Director, East
Monchiere Commodore
Global Field Medical Capabilities
Monica Timmerman
Director, Field Medical Capabilities
Mirati Therapeutics
Payal Patel
Director, Field Medical Affairs
Sherri So
Senior Medical Science Liaison
Cara Therapeutics
Sonish Azam
Oncology Medical Science Liaison
Kyowa Kirin
Stacey Gorski
Director, Medical Excellence & Strategic Projects
Sanofi Pasteur
Taylor Spector
Associate Director, Digital Innovation & Operational Excellence
Tiffany Scott-Horton
Medical Science Liaison
Boehringer Ingelheim
Tracy Nicholson
Medical Science Liaison
Vanessa Jacobsen
Executive Director, Medical Science Liaisons
Nektar Therapeutics
Vruti Patel
Regional Medical Affairs Director
Event Schedule
Some people are natural born leaders, possessing traits such as self-confidence, extroversion, and high emotional intelligence. However, not every person who becomes a leader has these traits and not every person who has these traits becomes a leader. So, what are the key qualities that distinguish great MSL leaders?
  • Identify the skills and attributes of successful medical affairs leaders
  • Leverage the diversity of backgrounds and experiences within your team
  • Share educational resources for MSL leaders and aspiring leaders
Throughout the course of this pandemic, MSLs have shown their value by staying agile in addressing HCP needs and embracing a wider breadth of medical affairs responsibilities. Given the highly competitive MSL market, what can companies do to retain high-performing, talented field medical professionals?
  • Re-strategize ways to keep field teams motivated and engaged with the organization
  • Define career paths and opportunities for advancement to minimize turnover
  • Address latest compensation trends
Career paths for MSLs can sometimes be hard to navigate. Some MSLs feel stuck in their role and believe they may be limited in their options for career advancement unless they are willing to relocate. With more positions available in the field, what can MSLs do to set themselves up for their next role?
  • Define your career objectives and set actionable goals for professional development
  • Select and engage mentors who can help you achieve your goals
  • Position your skills to show value to the organizations
In today’s tight job market, creating genuine relationships with recruiters is more important than ever. Recruiters can provide more than just job opportunities – they can be offer expert advice on the job market, career advancement opportunities and skill building opportunities.
  • Tips to build a strong two-way relationship with a recruiter
  • Understand the capabilities and culture of the agency
  • Foster relationships in the virtual recruiting
Medical Affairs leaders agree that virtual interviews will continue post-pandemic. From testing out technologies in advance to dressing the part, what can MSLs do to make certain they ace their next virtual interview?
  • Set a checklist to ensure preparedness
  • Develop a confident and engaging room presence
  • Treat your interview like a KOL meeting
Since the pandemic, medical affairs leaders have been challenged with finding creative ways to onboard new MSLs and develop comradery in a virtual setting.
  • Create a win-win scenario in onboarding – how to train new hires while developing current team members
  • It takes a village – how to incorporate all members of your field based medical team in the onboarding process
  • Empower teams to build relationships and comradery within the organization
Face-to-face interactions are making a comeback; however, many practitioners may want to continue to engage virtually. MSLs can continue to build upon their virtual meeting skills to ensure that they are having meaningful and impactful conversations.
  • Maintain awareness of your surroundings during virtual engagements
  • Emphasize spatial design and professional presentation during video conference
  • Best practices to maximize the capabilities of your virtual platform
One of the most exciting things about field medical is how the role continues to evolve. As MSLs continue to adapt to new digital technologies and a more hybrid role, there are several best practices that will ensure success. Join our panel of MSLs and medical affairs leaders as they share their tips for success.
  • Address best practices and core competencies in field medical
  • Review global MSL practices for KOL outreach and engagement
  • Explore different field medical roles and their functions
The MSL role is entirely scientific and non-promotional making it difficult for many organizations to evaluate the effectiveness of field medical teams. Companies are starting to move away from standard quantitative metrics, and now rely on holistic approaches for measuring the impact the field medical team.
  • Present the value of an MSL organization to leadership
  • Educate MSLs on the KPIs they will be evaluated on and the importance of each metric
  • Assign a value to virtual engagements
  • Allow MSLs to contribute to defining a strategy that shows their worth
With so much uncertainty surrounding the pandemic, MSLs are challenged with building and maintaining many of their relationships virtually. While MSLs are experts in communicating complex scientific data, many struggle to add their personal touch and keep virtual engagements conversational.
  • Understand the needs of the HCP and what drives their decisions
  • Develop content that is engaging and encourages HCPs to ask questions and provide insights
  • Incorporate empathy and emotional intelligence in each virtual engagement
  • Reshape data into a patient-centric narrative
MSLs have recently taken on a greater role in all stages of a product lifecycle from clinical development to post-launch. Many organizations are also engaging MSLs in project work that aligns with the medical affairs strategy.
  • Understand the diverse projects MSLs are engaged in at different companies
  • Leverage the diversity and field experience of MSLs in strategic organizational projects
  • Best practices and scenarios that inspire brainstorming and spur creative ideas
Access to KOLs and institutions is always a major challenge for MSLs and field medical professionals. In this uncertain environment, MSLs need to identify and build credibility with new KOLs to engage them in robust scientific discussions.
  • Unique ways to connect and solidify relationships with KOLs when there is no pre-existing relationship
  • Develop a methodical approach to territory management
  • Demonstrate impact and prove MSL value beyond the first meeting
The evolution of digital technology fast-forwarded during the pandemic, and many key opinion leaders are increasingly comfortable with digital engagement. As companies implement omni-channel strategies for engagement, MSLs will need to adapt to effectively operate in this new environment.
  • Understand how omni-channel services transform the medical affairs engagement model
  • Embrace AI and other digital advancements to predict the best path to educating HCPs
  • Incorporate technology to optimize the work of field medical teams
From trendy Tik-Toks to discussing the latest study on Twitter, nearly two-thirds of HCPs utilize some form of social media for professional reasons. Social media presents an incredible opportunity for MSLs gain insights from traditional KOLs and the newer DOLs.
  • Determine which channels and approaches are most effective in generating insights
  • Review best practices for identifying and engaging with digital opinion leaders
  • Address compliance concerns that arise from social media interactions
A key metric for most field medical teams is the quantity of KOLs engagements. However, MSLs need to bring back relevant and actionable insights from these meetings to provide value to their organization.
  • Understand the gap between insights and information
  • Review effective insight-gathering methods to optimize MSL performance
  • Interpret and communicate insights to internal stakeholders (commercial, market access, etc.) in a meaningful manner
Despite unprecedented challenges with the pandemic, the FDA did not slow down their efforts in reviewing and approving new therapies. According to the Center for Drug Evaluation and Research (CDER), there were a total of 53 novel drugs approved in 2020, the second highest count in over 20 years. MSLs and medical affairs teams need to appropriately align their resources to prepare for a successful launch.
  • Best practices and tips for success from successful virtual launches
  • Train and build enthusiasm within the team when a live launch meeting is not feasible
  • Define your KOL universe and territory management plan
As managed care organizations become more interested in the science behind a therapeutic, companies depend on their expert field medical teams to communicate the value proposition of the drug/device to payer groups. These roles may be siloed at some organizations; however, there are significant opportunities for synergy between medical and HEOR teams.
  • Define the subtle nuances between traditional MSLs and MVL/MCLs
  • Understand payer trends and balance messaging to emphasize HEOR data
  • Bridge gaps and establish ongoing relationships with payer organizations
Register Now

This window is secured by 256 bit encryption on a PCI compliant network. Click here to view this window in its own page.

Subscribe to Conference Updates
Join our e-newsletter list to follow closely all news.
Event Partners
Contact Us
Hotel Info & Reservations
Venue Details

A block of rooms has been reserved at a discounted rate for our conference participants. To reserve a room, please visit https://book.passkey.com/e/50233885 or call 215-823-6240 and reference the special rate “DGEB.” The discounted reservation rate will be in effect until JANUARY 17, 2022.

DGE is not affiliated with any third-party booking agencies, bureaus or travel companies. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at info@dgevents.com. DGE has not authorized these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through DGE’s reserved guest room block using the details provided.